Neuroscientific Biopharmaceuticals (ASX:NSB) Accounts Payable & Accrued Expense : A$0.11 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals Accounts Payable & Accrued Expense?

Neuroscientific Biopharmaceuticals's quarterly accounts payable & accrued expense declined from Dec. 2022 (A$1.04 Mil) to Jun. 2023 (A$0.59 Mil) and declined from Jun. 2023 (A$0.59 Mil) to Dec. 2023 (A$0.11 Mil).

Neuroscientific Biopharmaceuticals's annual accounts payable & accrued expense increased from Jun. 2021 (A$0.18 Mil) to Jun. 2022 (A$2.17 Mil) but then declined from Jun. 2022 (A$2.17 Mil) to Jun. 2023 (A$0.59 Mil).

Neuroscientific Biopharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Accounts Payable & Accrued Expense Chart

Neuroscientific Biopharmaceuticals Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

0.04

0.06

0.18

2.17

0.59

Neuroscientific Biopharmaceuticals Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial							0.17	2.17	1.04	0.59	0.11

Neuroscientific Biopharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011

Website

https://www.neuroscientific.com

Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines